April 17, 2015

Evaluating Functional Magnetic Stimulation’s Potential to Improve Expiratory Function in MS Patients

Enabling them to cough reduces their pneumonia risk

LinZhang-690×380

There are approximately 400,000 patients with multiple sclerosis (MS) in the United States. A significant number are not able to produce an effective cough to clear airway secretions, due to impairment of the central nervous system controlling the respiratory muscles. The inability to effectively cough elevates the risk of pneumonia.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Cleveland Clinic’s Director of Rehabilitation Research, Vernon Lin, MD, PhD, found that a technique called functional magnetic stimulation (FMS) improves respiratory muscle conditioning and coughing in patients with chronic spinal cord injury (SCI). Dr. Lin and his team are now applying the technique to patients with expiratory muscle dysfunction (including abdominal muscle weakness) due to MS.

“Expiratory muscle strength in patients with MS is significantly lower ‒ 27 percent to 74 percent of predicted ‒ than in normal subjects,” says Xiaoming Zhang, PhD, of Cleveland Clinic’s Department of Physical Medicine and Rehabilitation. “This can have a deleterious effect on their health, and they are more prone to develop pneumonia, which can be fatal.”

FMS is a painless, noninvasive technique that activates targeted muscles by stimulating corresponding spinal nerves where they exit the spinal cord. For patients with SCI and MS, FMS may substitute as a passive form of neuromuscular exercise.

LinZhang-fig1

“Our laboratory has demonstrated the efficacies of FMS in improving physiological functions for patients with SCI, including improving coughing, breathing, bladder emptying, gastrointestinal motility and fibrinolysis, resulting in prevention of deep venous thrombosis,” says Dr. Zhang. “We are very optimistic that FMS will prove to be an effective tool for conditioning the expiratory muscles and improving quality of life in patients with MS.”

Advertisement

How Stimulation Is Accomplished

Functional magnetic stimulators consist of two components: a pulse generator producing discharge currents of 5,000 amps and a stimulating coil producing magnetic pulses with field strength of 2 Tesla and duration of about 250 μs. The magnetic field induces an electric field that excites neurons.

Placement of the coil varies with the therapeutic goal. In previous studies of FMS in SCI, lower thoracic spinal nerve stimulation resulted in maximal stimulation of expiratory muscles. Four to six weeks of conditioning of these expiratory muscles led to significant improvement in their voluntary expiratory functions, such as airway pressures, volumes and flow rates.

To study the effects of FMS in MS patients, researchers placed the center of the coil at the T9 spinous process and activated the stimulator for 20 minutes per day. The therapy was provided five days a week for six weeks, with stimulation intensity gradually increased from 40 percent to 70 percent of maximal capacity.

Preliminary Results Show Improvement

Pulmonary function tests performed at baseline and every two weeks measured maximal expiratory pressure, peak expiratory flow and expiratory reserve volume. The researchers observed continual improvements. At the end of the six-week study protocol, patients experienced a 20 percent increase over baseline in expiratory muscle strength, as measured by pressure.

“This increase is significant and may prevent pneumonia,” says Dr. Zhang. “However, these results are preliminary and will be used to apply for external funding for a more comprehensive study. When FMS units can be used at home, patients with MS may benefit from a more long-term and more convenient way of stimulating their respiratory muscles.”

Advertisement

Dr. Lin is Cleveland Clinic’s Director of Rehabilitation Research. Dr. Zhang is a Research Engineer in the Department of Physical Medicine and Rehabilitation.

Related Articles

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

22-NEU-2959102-CQD-Hero-650×450
June 15, 2022
MINDS Study Will Assess Lifestyle Interventions for Slowing Brain Pathology in Preclinical Stages

New grant-funded investigation illustrates impact and reach of Cleveland Clinic Brain Study

22-NEU-2671014-CQD-650×450-Type
March 9, 2022
A Closer Look at the Cleveland Clinic Brain Study

How the new longitudinal investigation could become the Framingham Heart Study of brain health

20-NEU-1959738 powered-exoskeleton-for-gait-training_650x450
October 23, 2020
Study Signals Potential of Powered Exoskeleton for Gait Training in Multiple Sclerosis

Pilot findings show good patient acceptance and safety, early hints of efficacy

20-NEU-1990660-sleep-symptoms-in-health-workers-650×450
October 21, 2020
Electronic Screening for Sleep Disorders Among Healthcare Workers Is Feasible – and Sorely Needed

Study finds high prevalence of symptoms, willingness to seek treatment

20-NEU-1946228 neurofilaments_650x450
September 9, 2020
Serum Neurofilament Light as a Progressive MS Biomarker: Guideposts for the Road Ahead

Panel outlines research priorities around a promising alternative to imaging markers

20-NEU-1951118_Impella-temporary-LVAD_650x450_ (1)
September 4, 2020
Study Finds Clues to Acute Neurologic Events With Short-Term Impella Cardiac Support

Suspected factors include antithrombotic intensity, time on device, presence of thrombocytopenia

20-NEU-1929179 deep-brain-stimulation-for-TBI_650x450
September 3, 2020
Could DBS of the Cerebellar Dentate Nucleus Enhance Post-TBI Rehabilitation?

Preclinical studies will assess whether method developed for stroke recovery curbs deficits after brain injury

Ad